###begin article-title 0
###xml 31 39 <span type="species:ncbi:9606">Patients</span>
Monocytes from Cystic Fibrosis Patients Are Locked in an LPS Tolerance State: Down-Regulation of TREM-1 as Putative Underlying Mechanism
###end article-title 0
###begin p 1
Conceived and designed the experiments: ELC FGR. Performed the experiments: CdF VL VGP ASS BR IFR FGR ECG. Analyzed the data: ELC CdF VGP RAS TV FG FA FGR PFP. Wrote the paper: ELC FA.
###end p 1
###begin p 2
###xml 0 1 0 1 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 7 8 7 8 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</underline>
###xml 138 139 138 139 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 145 146 145 146 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</underline>
###xml 154 155 154 155 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 180 181 180 181 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 630 631 630 631 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 641 642 641 642 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</underline>
###xml 650 651 650 651 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</underline>
###xml 663 664 663 664 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</underline>
###xml 949 950 949 950 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 957 958 957 958 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</underline>
###xml 969 970 969 970 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</underline>
###xml 979 980 979 980 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</underline>
###xml 1019 1026 1019 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 1125 1126 1125 1126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1296 1297 1296 1297 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 449 457 <span type="species:ncbi:9606">patients</span>
###xml 724 732 <span type="species:ncbi:9606">patients</span>
###xml 874 882 <span type="species:ncbi:9606">patients</span>
###xml 924 932 <span type="species:ncbi:9606">patients</span>
###xml 1196 1204 <span type="species:ncbi:9606">patients</span>
###xml 1603 1611 <span type="species:ncbi:9606">patients</span>
Cystic Fibrosis (CF) is an inherited pleiotropic disease that results from abnormalities in the gene that codes for the chloride channel, Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). CF patients are frequently colonized by several pathogens, but the mechanisms that allow colonization in spite of apparently functional immune systems are incompletely understood. In this paper we show that blood peripheral monocytes isolated from CF patients are found in an endotoxin tolerance state, yet this is not due to a deficient TLR activation. On the other hand, levels of the amplifier of inflammatory responses, TREM-1 (Triggering Receptor Expressed on Myeloid cells), are notably down-regulated in monocytes from patients, in comparison to those extracted from healthy volunteers. Furthermore, the soluble form of TREM-1 (sTREM-1) was not detected in the sera of patients. Additionally, and in strict contrast to patients who suffer from Chronic Obstructive Pulmonary Disease (COPD), CF monocytes challenged ex vivo with LPS neither up-regulated membrane-anchored TREM-1 nor sTREM-1. Finally, similar levels of PGE2 expression and p65 translocation into the nucleus were found in both patients and healthy volunteers, thus suggesting that TREM-1 regulation is neither controlled by PGE2 levels nor by p65 activation in this case. However, PU.1 translocation into the nucleus was significantly higher in CF monocytes than in controls, suggesting a role for this transcription factor in the control of TREM-1 expression. We conclude that down-regulation of TREM-1 expression in cystic fibrosis patients is at least partly responsible for the endotoxin tolerance state in which their monocytes are locked.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 340 343 340 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Rowe1">[1]</xref>
###xml 345 348 345 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gadsby1">[2]</xref>
###xml 651 654 651 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Rowe1">[1]</xref>
Cystic fibrosis (CF), also called mucoviscidosis, is a complex, pleiotropic disease that affects all exocrine epithelia. CF results from abnormalities in the gene that codes for the chloride channel termed CF Transmembrane Conductance Regulator (CFTR), which belongs to the extended family of ATP-binding cassette (ABC) transporter ATPases [1], [2]. This transmembrane glycoprotein is expressed in some epithelia, and controls chloride flux across cell surfaces. In addition, it down-regulates transepithelial sodium transport, regulates calcium-activated chloride channels and potassium channels, and may also serve important functions in exocytosis [1].
###end p 4
###begin p 5
###xml 332 335 332 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Ratjen1">[3]</xref>
###xml 551 554 551 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Sibley1">[4]</xref>
###xml 1150 1153 1150 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Ramsey1">[5]</xref>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
###xml 391 399 <span type="species:ncbi:9606">patients</span>
###xml 542 550 <span type="species:ncbi:9606">patients</span>
###xml 626 634 <span type="species:ncbi:9606">patients</span>
###xml 1243 1251 <span type="species:ncbi:9606">patients</span>
Some clinical features of CF include injuries of primary organs (pancreas, sinus, liver, intestine and exocrine pancreas) and secondary complications such as malnutrition, and diabetes. However, morbidity and mortality of CF patients are usually the result of chronic lower airway bacterial infections and inflammation of the lungs [3]. Repeated episodes of polymicrobial infection in these patients cause a progressive deterioration of lung tissue, a decline in pulmonary function and, ultimately, respiratory failure and death in 90% of CF patients [4]. In spite of the critical role played by pulmonary infections in these patients, the host factors that permit bacterial endobronchial colonization of the CF airway are poorly understood. It has been proposed that defective transmembrane conductance facilitates bacterial adherence to the respiratory epithelium, and that alterations in the sodium and chloride concentrations in the periciliary fluid impair the activity of defensins. Other authors claim that a deficit of hydrophilic surfactant proteins contributes to the inefficiency of the cellular inflammatory response to invading bacteria [5]. These observations, in turn, point to a deregulation of the innate immune systems in CF patients, and provoke a thorough analysis of the interplay between bacterial and host factors.
###end p 5
###begin p 6
###xml 276 279 276 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Bouchon1">[6]</xref>
###xml 281 284 281 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-KlesneyTait1">[7]</xref>
###xml 442 445 442 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Bouchon1">[6]</xref>
###xml 447 450 447 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-KlesneyTait1">[7]</xref>
###xml 452 455 452 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Knapp1">[8]</xref>
###xml 457 460 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-GomezPina1">[9]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot1">[10]</xref>
###xml 765 772 765 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 786 792 786 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TREM-1</italic>
###xml 903 906 903 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-KlesneyTait1">[7]</xref>
###xml 908 912 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot1">[10]</xref>
###xml 914 918 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Haselmayer1">[11]</xref>
###xml 1170 1174 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Mohamadzadeh1">[12]</xref>
###xml 1176 1180 1176 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Murakami1">[13]</xref>
###xml 1182 1186 1182 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Tejera1">[14]</xref>
###xml 1294 1295 1294 1295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1433 1437 1433 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Murakami1">[13]</xref>
###xml 816 821 <span type="species:ncbi:10090">mouse</span>
Recently, the immunoglobulin-related transmembrane receptor termed triggering receptor expressed on myeloid cells, (TREM)-1, has been recognized as an important element of the immune response, which strongly enhances leukocyte activation in the presence of microbial products [6], [7]. TREM-1 is mainly expressed on monocytes and neutrophils, and its levels at cell surface are up-regulated upon challenge with LPS or other microbial stimuli [6], [7], [8], [9]. Although the cellular signaling events downstream of TREM-1 engagement are incompletely understood, recently reported data suggest that receptor expression is essential for mounting an adequate inflammatory and cytotoxic response to polymicrobial sepsis [10]. This has been particularly demonstrated by in vivo silencing of TREM-1 in a fecal peritonitis mouse model, which resulted in a blunted inflammatory response and increased mortality [7], [10], [11]. Also along these lines, receptor expression is significantly higher in the course of infectious diseases. Current evidence suggests that TREM-1 levels could represent a valuable marker of infection in several pathological conditions including sepsis [12], [13], [14]. LPS-induced receptor expression appears to be at least partly mediated by endogenous prostaglandin E2 (PGE2); this triggers EP4- and cAMP/protein kinase A-dependent mechanisms that are followed by p38 MAPK activation and PI3K-mediated signaling [13].
###end p 6
###begin p 7
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot2">[15]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot3">[16]</xref>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Determann1">[17]</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot4">[18]</xref>
###xml 387 390 387 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-KlesneyTait1">[7]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot2">[15]</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot5">[19]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Horonenko1">[20]</xref>
###xml 535 541 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot5">[19]</xref>
###xml 872 876 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot4">[18]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot4">[18]</xref>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Liu1">[21]</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-How1">[22]</xref>
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 352 360 <span type="species:ncbi:9606">patients</span>
###xml 526 534 <span type="species:ncbi:9606">patients</span>
In addition to the membrane-bound form, a soluble TREM-1 variant (sTREM-1) has been detected in mouse and human serum [15], [16]. In particular, clinical studies have reported the presence of sTREM-1 in patients' serum and in bronchioalveolar lavage fluid [17], [18]. This soluble form has been found at particularly high concentrations in fluids from patients with microbial infections [7], [15], [19] and with ventilator-associated pneumonia [20]. Other authors also report an up-regulation of sTREM-1 in plasma from septic patients versus those suffering from systemic inflammatory response syndrome (SIRS) [19]. Altogether, current evidence strongly suggests an important role for sTREM-1 in the evolution of infectious diseases, and indicates that the soluble receptor form represents a useful marker of infection, particularly for the diagnosis of nosocomial sepsis [18] and pneumonia [18], [21], [22].
###end p 7
###begin p 8
###xml 187 190 187 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-KlesneyTait1">[7]</xref>
###xml 462 465 462 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-GomezPina1">[9]</xref>
Two possible sources of sTREM-1 have been postulated: translation of an alternative TREM-1 mRNA splice variant and proteolytic cleavage (shedding) of mature, cell surface-anchored TREM-1 [7]. We have recently described that matrix metalloproteinases (MMPs) are responsible for shedding TREM-1 ectodomain from the cell membrane, most likely through proteolytic cleavage of a single peptide bond within the long juxtamembrane linker of the membrane-bound receptor [9]. These findings imply that sTREM-1 generation requires a previous expression of the membrane-anchored receptor.
###end p 8
###begin p 9
###xml 698 705 698 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 469 477 <span type="species:ncbi:9606">patients</span>
###xml 521 529 <span type="species:ncbi:9606">patients</span>
###xml 643 651 <span type="species:ncbi:9606">patients</span>
###xml 678 686 <span type="species:ncbi:9606">patients</span>
###xml 847 855 <span type="species:ncbi:9606">patients</span>
Here we have tested the hypothesis that the high frequency of infection observed in CF patients is at least partly the consequence of deregulated innate immune responses. To this end, we have explored the expression of (1) receptors involved in LPS recognition (CD14 and TLR4/MD2), (2) the down-regulator of the TLR pathway, IRAK-M, and (3) both membrane-bound and soluble forms of TREM-1. We demonstrate that TREM-1 levels are clearly down-regulated in monocytes from patients when compared to healthy volunteers and to patients suffering from another pulmonary disease, COPD. Further, sTREM-1 was not detected in the sera of cystic fibrosis patients, and monocytes from these patients challenged ex vivo with LPS neither up-regulated TREM-1 nor its soluble form. On the basis of these findings, we conclude that polymicrobial lung infections in patients who suffer from cystic fibrosis are due at least partly to a deficiency in their innate immune responses, and that impaired TREM-1 expression plays a role in this deficiency.
###end p 9
###begin title 10
Materials and Methods
###end title 10
###begin title 11
Reagents
###end title 11
###begin p 12
###xml 198 216 198 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella abortus</italic>
All reagents were of the highest quality available and were obtained from Merck (Darmstadt, Germany), Boehringer (Mannheim, Germany), or Sigma-Aldrich (St. Louis, MO). Lipopolysaccharide (LPS, from Salmonella abortus) was generously provided by Dr. Chris Galanos from the Max Planck Institut fur Immunobiologie, Freiburg, Germany. The anti-TREM-1 and anti-TLR4 antibodies were purchased from R&D Systems (MN, USA); anti-CD14-PE, anti-CD16b and anti-CD1a were obtained from Serotec (Oxford, UK), anti-p65 from Santa Cruz (CA, USA), and anti-PU.1 from Cell Signaling (Danvers, MA).
###end p 12
###begin title 13
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and controls
###end title 13
###begin p 14
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Rosenstein1">[23]</xref>
###xml 358 359 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 384 385 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 421 425 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Pauwels1">[24]</xref>
###xml 865 866 863 864 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
We studied 20 non-smoker adults diagnosed with CF on the basis of established criteria (CFTR genotyping, sweat testing, and clinical phenotype) [23], who did not use inhaled or oral corticosteroids within the three months previous to the study. We also studied and ten consecutive clinically stable patients with moderate-severe COPD (post-bronchodilator FEV1<80% of predicted and FEV1/forced vital capacity (FVC)</=70%) [24]. Exclusion criteria included a history of asthma, other active lung disease, mental or physical handicap, or other significant diseases, such as congestive heart failure, ischemic or valvular cardiopathy or neuromuscular disease. None of the subjects had experienced an exacerbation or respiratory tract infection within the previous four weeks, and none of them showed significant bronchodilator reversibility (either >12% of baseline FEV1 or >200 ml). No subject has had oral corticosteroid therapy for at least three months. Moreover, ten sex- and age-matched healthy volunteers without neither personal history of CF nor other significant illness were also included as controls.
###end p 14
###begin p 15
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Mahler1">[25]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Celli1">[26]</xref>
###xml 391 399 <span type="species:ncbi:9606">patients</span>
###xml 538 546 <span type="species:ncbi:9606">patients</span>
###xml 667 675 <span type="species:ncbi:9606">patients</span>
The following clinical variables were collected on each subject using chart review: age, sex, body mass index, CFTR genotype, dyspnea evaluated by the modified Medical Research Council (MRC) scale [25], arterial blood gases, basal spirometry, moderate-severe COPD exacerbations in the last year, COPD severity [26], microorganisms in sputum, and usual therapy. Blood samples were taken from patients and healthy donors. Peripheral blood mononuclear cells (PBMCs) were isolated and monocytes cultured under various conditions. Plasma from patients and healthy donors was also used for other assays (see below). Written informed consent was obtained from all subjects (patients and healthy volunteers). This study was approved by the local Ethics Committee (La Paz Hospital Ethics Committee, Paseo de La Castellana 261, Madrid 28046).
###end p 15
###begin title 16
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human monocytes isolation and culture
###end title 16
###begin p 17
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Escoll1">[27]</xref>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-delFresno1">[28]</xref>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 425 426 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 515 521 <span type="species:ncbi:9913">bovine</span>
PBMCs were isolated from blood of healthy donors and CF patients by centrifugation on Ficoll-Hypaque Plus (Amershan Biosciences, Netherlands) following previously reported protocols [27], [28]. Cells were initially cultured for 2 h to a density of 106 cells/ml in DMEN supplemented with antibiotics (100 IU/ml penicillin and 100 microg/ml streptomycin). After this period, the supernatant was removed and adherent cells (2x106 per well) were cultured in the same medium supplemented with 10% heat-inactivated fetal bovine serum. Purity of all cultures was verified by CD14+ staining; on average 89% of the cells presented this surface marker. Cells were then cultured in the presence or absence of 10 ng/ml LPS for different periods of time (range: from 1 to 16 hours).
###end p 17
###begin title 18
FACS analysis of CD14, TLR4/MD2 and TREM-1 expression
###end title 18
###begin p 19
###xml 38 46 <span type="species:ncbi:9606">patients</span>
###xml 156 160 <span type="species:ncbi:9925">goat</span>
Monocytes from healthy volunteers and patients were washed in PBS and incubated with anti-CD14, anti-TREM-1 or anti-TLR4/MD2 antibodies followed by an anti-goat FITC-conjugated secondary polyclonal antibody (Jackson Immunoresearch, Baltimore, USA). To correct unspecific binding, appropriate isotype control antibodies were used. For double staining (CD14 and TREM-1), cells were incubated with a CD14- allophycocyanin (APC)-conjugate (Miltenyi, Bergisch Gladbach, Germany). Samples were analyzed by flow cytometry using a BD FACSCalibur flow cytometer (BD Biosciences, San Diego, CA) equipped with a 25 mW argon laser. The same protocol was followed in cases of cultures stimulated with LPS.
###end p 19
###begin title 20
ELISA quantitation of sTREM-1
###end title 20
###begin p 21
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Concentrations of sTREM-1 in supernatants of human monocyte cultures from patients and controls were determined using a commercially available ELISA (DuoSet, R&D Systems), following the manufacturer's instructions (lower limit of detection: 15 pg/ml).
###end p 21
###begin title 22
Immunohistochemistry
###end title 22
###begin p 23
Cells were fixed for 15 min with 2% paraformaldehyde in PBS, pH 7.3. Then, samples were blocked using a blocking serum (Universal Quick Kit, Vector Laboratories, CA), rinsed, and finally labeled by incubating overnight at 4 degreesC with anti-TREM-1 antibody diluted 1:1,000 in PBS. The cells were washed twice in 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.2% Tween 20 (TTBS) and incubated with a secondary FITC-conjugated antibody (1:4,000) for one hour. After rinsing with TTBS, cell nuclei were labeled by incubating with Hoechst 33342 (Molecular Probes), a cell-permeable fluorescent die that can therefore stain nuclei of both living and fixed cells. Briefly, Hoechst stock solution (2 mM in saline) was diluted in PBS (1:8,000) and cells were incubated with this solution for 5-10 minutes at room temperature. Samples were then rinsed three times with PBS, excess buffer was drained, and samples finally mounted in anti-fade mounting medium. Cells were viewed and photographed on a Leica DMI6000 B (Leica Microsistemas, S.A.).
###end p 23
###begin title 24
RNA and protein isolation
###end title 24
###begin p 25
Cells were washed once in PBS and their RNA was isolated using TRI-Reagent (IMICO, Cincinnati, OH). Purified RNA was treated with RNase-free DNase I (Amersham Biosciences) and cDNA was obtained by reverse transcription of 1 microg RNA using a poly(dT) oligonucleotide primer (Roche, Palo Alto, CA). Protein fractions were isolated as recommended (Roche), and the final pellets were dissolved in a solution containing 1% SDS.
###end p 25
###begin title 26
mRNA quantification
###end title 26
###begin p 27
###xml 300 307 296 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002667-t001">Table 1</xref>
###xml 363 366 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18S</italic>
###xml 555 556 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1394 1401 1372 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002667-t002">Table 2</xref>
The expression levels of TNFalpha, IL-6, IRAK-M, and 18S were analyzed by real time Q-PCR (LightCycler; Roche Diagnostics, Indianapolis, IN), using cDNA obtained as described above. Real time Q-PCR was performed using a Fast-Start DNA master SYBR Green system (Roche) and specific primers (listed in Table 1). All results were normalized to the expression of the 18S gene, and the cDNA copy number of each gene of interest was determined using a seven-point standard curve. Standard curves were run with each set of samples, the correlation coefficients r2 being >0.99. To confirm the specificity of the reaction products in each experiment, the melting profile of each sample was analyzed using the LightCycler. Melting profiles were determined by maintaining the reactions at 80degreesC for 10 s and then increasing the temperature to 95degreesC at a linear rate of 0.1degreesC/s while measuring the emitted fluorescence. Analysis of the melting curves demonstrated that each pair of primers amplified a single product. PCR products were separated in agarose gels and stained with ethidium bromide to confirm that in each case a single fragment of the predicted size had been amplified. For 18S mRNA detection we used the primers of QuantumRNA Classic 18S provided by Ambion, USA. All other primers were purchased from IZASA (Barcelona, Spain) and their specific PCR conditions are listed en Table 2.
###end p 27
###begin title 28
Sequences of oligonucleotides used for Q-PCR analysis.
###end title 28
###begin title 29
PCR conditions for mRNA quantitation.
###end title 29
###begin title 30
Isolation of nuclear proteins
###end title 30
###begin p 31
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-LopezCollazo1">[29]</xref>
###xml 199 200 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
A procedure based on the method reported by Lopez-Collazo et al[29] was used. Cells were washed twice with ice-cold PBS, and plates were filled with 0.4 ml Buffer A (20 mM Tris-HCl, pH 7.8, 5 mM MgCl2, 10 mM KCl, 0.5 mM EGTA, 0.5 mM DTT, 1 mM PMSF, and 10 microM leupeptin). The cells were scraped off the dishes using a rubber policeman and transferred to 1.5-ml Eppendorf tubes, to which Nonidet P-40 was added to reach a 0.5% final concentration. The tubes were gently vortexed for 15 s and nuclei were sedimented by centrifugation at 8,000xg for 15 s. Aliquots of the supernatant were stored at -80degreesC (cytosolic extract), and the nuclear pellet was resuspended in 100 microl Buffer A supplemented with 0.4 M KCl. Nuclear proteins were extracted by centrifugation at 13,000xg for 15 min, and aliquots of the supernatant were stored at -80degreesC. All steps of cell fractionation were conducted at 4degreesC.
###end p 31
###begin title 32
SDS-PAGE and Western blotting
###end title 32
###begin p 33
Cell extracts and nuclear proteins were boiled in Laemmli buffer, resolved on 15% SDS-polyacrylamide gels in Tris/glycine/SDS buffer, and transferred to Immun-Blot PVDF Membranes (Bio-Rad, CA) at 300 mA for 1.5 h at 4degreesC. After blocking for 1 h in TTBS containing 5% non-fat milk, membranes were washed three times in TTBS alone and probed for 20 h with anti-TREM-1, anti-p65 or anti-PU.1 antibodies diluted in TTBS. Following extensive washing in TTBS, membranes were incubated for 45 min with a secondary HRP-conjugated antibody (diluted 1:4,000), and finally washed three times with TTBS. The bound antibodies were detected using ECL Plus reagents according to the manufacturer's instructions (Amersham-Pharmacia Biotech, Holland).
###end p 33
###begin title 34
Prostaglandin E2 quantitation
###end title 34
###begin p 35
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
Levels of PGE2 in sera and supernatants of cultures of monocytes from CF patients and healthy controls were measured using a commercial available kit (R&D Systems) and following the manufacturer's instructions.
###end p 35
###begin title 36
Data analysis
###end title 36
###begin p 37
The number of experiments analyzed is indicated in each figure. The statistical significance was calculated using the unpaired Student's test and differences were considered significant at p values<0.05.
###end p 37
###begin title 38
Results
###end title 38
###begin title 39
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 39
###begin p 40
###xml 93 100 93 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002667-t003">Table 3</xref>
###xml 157 158 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 196 197 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 551 573 535 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 395 403 <span type="species:ncbi:9606">patients</span>
###xml 551 573 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 611 619 <span type="species:ncbi:9606">patients</span>
Clinical and genetic data of CF patients included in the current study (n = 20) are shown in Table 3. Their mean age was 30+/-10 years (mean+/-SD); their FEV1 (% predicted) was 61+/-21%, their FEV1/FVC ratio 69+/-102% and the mean incidence of pulmonary exacerbations in the previous year was 1.8 episodes (range, 0-5). In agreement with the genetic distribution in the Spanish population, nine patients (45%) were homozygous for the CFTR variant DeltaF508 and other nine were compound heterozygotes, with one copy of DeltaF508 plus another mutation. Pseudomonas aeruginosa colonization was identified in 14 CF patients (70%).
###end p 40
###begin title 41
###xml 78 97 78 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium avium</italic>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 73 76 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 78 105 <span type="species:ncbi:37162">Mycobacterium avium complex</span>
Clinical data of cystic fibrosis patients included in the current study. MAC, Mycobacterium avium complex.
###end title 41
###begin p 42
###xml 95 96 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 128 129 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 153 160 147 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002667-t004">Table 4</xref>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
Mean age of moderate-severe COPD patients was 69+/-7 years, with a mean post-bronchodilator FEV1 of 53+/-20% predicted and a FEV1/FVC ratio of 45+/-12% (Table 4). The incidence of COPD exacerbations (2.2 episodes/year) was similar to that of the CF patients. All patients were informed of our study. This study was approved by the local Ethics Committee (La Paz Hospital Ethics Committee, Paseo de La Castellana 261, Madrid 28046).
###end p 42
###begin title 43
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Clinical data of Chronic Obstructive Pulmonary Disease patients included in the current study. NAC, N-Acetyl-Cystein, em leader
###end title 43
###begin title 44
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Circulating monocytes from cystic fibrosis patients fail to mount an appropriate inflammatory response in the presence of Gram-negative endotoxin
###end title 44
###begin p 45
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Govan1">[30]</xref>
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Saiman1">[31]</xref>
###xml 583 598 579 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g001">Fig. 1, A and B</xref>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
###xml 418 426 <span type="species:ncbi:9606">patients</span>
Because CF patients are frequently colonized by different bacteria [30], [31], we decided to study innate immune responses in circulating monocytes isolated from these patients. First, we cultured these cells in the presence or absence of LPS for 1, 6 or 16 hours, and verified production of pro-inflammatory cytokines. This analysis revealed low TNFalpha and IL-6 mRNA expression levels in monocytes isolated from CF patients (in following termed CF monocytes), while cells from healthy volunteers were able to induce significant amounts of these two cytokines after LPS challenge (Fig. 1, A and B). We note in particular that one-hour LPS treatment was enough to induce a clear expression of TNFalpha mRNA, which remained high for at least six hours. By contrast, CF monocytes failed to potently up-regulate this cytokine. Similar results were observed with IL-6 levels, but maximal expression in healthy volunteers was observed 6 h after LPS challenge, and the difference between normal and CF monocytes was not so pronounced.
###end p 45
###begin title 46
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Inflammatory responses are impaired in monocytes from CF patients.
###end title 46
###begin p 47
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
###xml 767 775 <span type="species:ncbi:9606">patients</span>
Monocytes from healthy volunteers (control, gray bars, n = 10) and from CF patients (CF, solid bars, n = 20) were cultured in the presence of 10 ng/ml LPS for indicated times. Cells were harvested, total RNA isolated and cDNA synthesized. TNFalpha (A) and IL-6 (B) mRNA levels were analyzed by real time Q-PCR. The ratios [TNFalpha]/[18S] and [IL-6]/[18S] are depicted. **, p<0.01 with respect to healthy controls (C) Concentrations of TNFalpha were determined in supernatants of cultures of human monocytes from healthy volunteers (control, gray bars, n = 10) and CF patients (CF, solid bars, n = 20), stimulated or not with 10 ng/ml LPS. *, p<0.05 with respect to healthy controls. (D) Monocytes isolated from healthy volunteers (control, gray bars, n = 10) and CF patients (CF, solid bars, n = 20) were stained with anti-CD14-PE, anti-CD16b or anti-CD1a antibodies and then analyzed by flow cytometry; the fraction of cells stained with each antibody is given.
###end p 47
###begin p 48
###xml 369 376 357 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g001">Fig. 1C</xref>
###xml 703 710 691 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g001">Fig. 1D</xref>
###xml 306 314 <span type="species:ncbi:9606">patients</span>
###xml 642 650 <span type="species:ncbi:9606">patients</span>
In addition, we also studied production of soluble TNFalpha in the supernatants of these cultures. In line with our findings regarding mRNA transcription, high levels of TNFalpha protein were detected 16 hours after LPS stimulation in monocytes isolated from healthy volunteers. By contrast, cells from CF patients produced about 2.5-times less TNFalpha than controls (Fig. 1C). Thus, we conclude that CF monocytes fail to mount a strong innate immune response upon LPS challenge. We note that all monocyte cultures were reasonably pure, as illustrated by the presence of an average of 89% CD14-positive cells in both healthy controls and CF patients, with negligible levels of CD16b and CD1a staining (Fig. 1D).
###end p 48
###begin title 49
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Circulating monocytes from CF patients exhibit normal levels of TLR4 and MD2 at their cell surface, and do not overexpress IRAK-M
###end title 49
###begin p 50
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 181 188 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g001">Figs 1D</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g002">2A</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Kim1">[32]</xref>
###xml 893 900 893 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g002">Fig. 2B</xref>
###xml 450 455 <span type="species:ncbi:9606">human</span>
###xml 868 876 <span type="species:ncbi:9606">patients</span>
Once established that CF monocytes fail to respond properly to ex vivo LPS challenge, and having observed similar levels of CD14 expression in these cells and in control monocytes (Figs 1D and 2A), we decided to analyze the expression of the two other proteins involved in LPS recognition and signaling, MD2 and TLR4. It is well known that this Toll-like receptor together with CD14 and the soluble carrier, MD2, form the receptor complex for LPS in human monocytes [32]. Thus, abnormalities in TLR4 and/or MD2 expression could offer a straightforward explanation for the LPS desensitization phenomenon observed in CF monocytes. However, and in contrast to our expectations, normal levels of these two proteins were found at the cell surface, and the flow cytometric analysis of TLR4/MD2 expression did not show significant differences between healthy controls and CF patients in this regard (Fig. 2B).
###end p 50
###begin title 51
Elements of the LPS receptor complex are expressed at similar levels in control and CF monocytes.
###end title 51
###begin p 52
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Monocytes isolated from healthy volunteers (control, gray bars, n = 10) and CF patients (CF, solid bars, n = 20) were stained with anti-CD14 and anti-TLR4/MD2 and then analyzed by flow cytometry; the fraction of cells stained is given (A and B respectively). Typical histograms are shown in the insets (I, isotype; Control, healthy volunteers; CF, Cystic Fibrosis).
###end p 52
###begin p 53
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-delFresno2">[33]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Escoll1">[27]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Kobayashi1">[34]</xref>
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-LopezCollazo2">[35]</xref>
###xml 585 591 585 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g003">Fig. 3</xref>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
We have previously described that the pseudokinase, IRAK-M, is overexpressed in monocytes from patients who suffer from Acute Coronary Syndrome, and is involved in the endotoxin tolerance phenomenon observed in these monocytes [33]. Next, and considering this negative role within the TLR signaling pathway, we determined IRAK-M expression levels in LPS-stimulated monocytes [27], [34], [35]. However, despite a slight tendency to IRAK-M down-regulation in CF monocytes compared to controls, no significant differences were observed in the kinetics of expression of this pseudokinase (Fig. 3).
###end p 53
###begin title 54
IRAK-M is normally induced in CF monocytes after LPS stimulation.
###end title 54
###begin p 55
###xml 258 278 258 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Material and Methods</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Cultures of human monocytes from healthy volunteers (control, gray bars, n = 10) and CF patients (CF, solid bars, n = 20) were treated with 10 ng/ml LPS for indicated times. Next, cells were harvested, total RNA isolated and cDNA synthesized as described in Material and Methods. The ratio of IRAK-M to 18S is shown.
###end p 55
###begin title 56
###xml 80 88 <span type="species:ncbi:9606">patients</span>
TREM-1 is expressed at low levels in circulating monocytes from cystic fibrosis patients
###end title 56
###begin p 57
###xml 26 34 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNF&#945;</italic>
###xml 39 43 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 45 51 41 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g001">Fig. 1</xref>
###xml 338 344 334 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g002">Fig. 2</xref>
###xml 377 383 373 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g003">Fig. 3</xref>
###xml 592 596 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Determann1">[17]</xref>
###xml 598 602 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot6">[36]</xref>
###xml 604 608 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Richeldi1">[37]</xref>
###xml 610 614 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot7">[38]</xref>
###xml 1091 1103 1087 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 1113 1116 1109 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Bouchon1">[6]</xref>
###xml 1118 1122 1114 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot8">[39]</xref>
###xml 773 781 <span type="species:ncbi:9606">patients</span>
Impaired up-regulation of TNFalpha and IL-6 (Fig. 1) would suggest that CF monocytes are not able to mount a strong inflammatory response after LPS challenge. This defective response to endotoxin is most likely not due to impaired LPS recognition by the MD2-CD14-TLR4 complex, as the three proteins are normally expressed in these cells (Fig. 2), nor to IRAK-M overexpression (Fig. 3). Therefore, we reasoned that a downstream positive feed-back loop could be affected in CF monocytes. Because of its repeated association with polymicrobial infections, and in particular with lung infections [17], [36], [37], [38], we hypothesized that decreased expression of another receptor involved in inflammatory responses, TREM-1, could lead to the observed LPS unresponsiveness in patients monocytes, with concomitant impairment of inflammatory responses. Although the actual role of TREM-1 in the innate immune response is not well understood, current evidence strongly supports a key role for this receptor as an amplifier of inflammatory responses, in particular during polymicrobial sepsis (see Introduction and refs [6], [39]).
###end p 57
###begin p 58
###xml 215 230 215 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g004">Fig. 4, A and B</xref>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
To verify this hypothesis, we compared TREM-1 levels in monocytes isolated from CF patients versus healthy volunteers. Indeed, a significant down-regulation of membrane-anchored TREM-1 was observed in CF monocytes (Fig. 4, A and B). These findings indicate that basal levels of TREM-1 are about two-fold lower in circulating monocytes from CF patients than in healthy individuals, and suggest a possible explanation for the observed inability of these cells to mount an inflammatory response.
###end p 58
###begin title 59
Expression levels of TREM-1 and sTREM-1 are low in CF monocytes.
###end title 59
###begin p 60
###xml 269 270 269 270 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</underline>
###xml 274 275 274 275 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</underline>
###xml 287 288 287 288 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</underline>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 474 482 <span type="species:ncbi:9606">patients</span>
###xml 790 798 <span type="species:ncbi:9606">patients</span>
###xml 1035 1040 <span type="species:ncbi:9606">Human</span>
(A) Monocytes isolated from healthy volunteers (controls, gray bars, n = 10) and CF patients (CF, solid bars, n = 20) were stained with anti-TREM-1-FITC and then analyzed by flow cytometry; the fraction of cells stained is given as % of total cells (left scale) and as mean fluorescence intensity (MFI, right scale). *, p<0.05 with respect to healthy controls. (B) A typical histogram obtained from flow cytometric analysis of TREM-1 expression is shown (I, isotype; CF, CF patients; Control, healthy volunteers). (C) The concentration of sTREM-1 in the supernatants of the same cultures was analyzed with a commercial ELISA. The mean concentration of sTREM-1 is represented. (D) Supernatants from monocyte cultures (one from a healthy volunteer (control) and two from randomly selected CF patients) were centrifuged at 400xg to remove detached cells and possible cellular debris. A Western blot analysis of these supernatants was performed using an anti-TREM-1 commercial antibody that recognizes the extra-cellular domain of TREM-1. Human monocytes challenged with LPS for six hours were used as positive control (+). Notice detection of a band of approximately 27 kDa in this condition (marked with an arrow). Loading controls are also shown (membrane stained with Ponceau red, lower panel). The results of a triplicated experiment are shown.
###end p 60
###begin p 61
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-GomezPina1">[9]</xref>
###xml 329 332 329 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Knapp1">[8]</xref>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot3">[16]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Tejera1">[14]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot2">[15]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Determann1">[17]</xref>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot4">[18]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot5">[19]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Horonenko1">[20]</xref>
###xml 744 747 744 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-GomezPina1">[9]</xref>
###xml 1328 1335 1328 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g004">Fig. 4C</xref>
###xml 1405 1412 1405 1412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g004">Fig. 4D</xref>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 524 529 <span type="species:ncbi:9606">human</span>
###xml 885 893 <span type="species:ncbi:9606">patients</span>
###xml 1141 1149 <span type="species:ncbi:9606">patients</span>
###xml 1295 1303 <span type="species:ncbi:9606">patients</span>
We have recently reported that expression levels of TREM-1 at the monocyte surface are controlled by endogenous metalloproteinases, which cleave membrane-anchored TREM-1 to generate the soluble form, sTREM-1 [9]. High levels of soluble TREM-1 have been identified by others in patients suffering from diverse infectious diseases [8], [16] and in particular in their fluids [14], [15], [17], [18], [19], [20]. Our previous findings suggest that LPS first induces an appreciable up-regulation of TREM-1 at the cell surface of human monocytes, but this membrane-anchored form is subsequently downregulated due to enhanced metalloproteinase production and/or activation, which generates sTREM-1 via proteolytic cleavage of the full-length receptor [9]. Thus, these clear differences in TREM-1 levels at the monocyte surface could be explained by the presence of a pathogen infection in CF patients. In particular, LPS generated by Gram-negative pathogens could induce metalloproteinase expression and activation, and concomitant shedding of TREM-1 extracellular domain. To test this possibility we compared the levels of sTREM-1 in sera from CF patients vs. healthy controls. However, no significant differences were found between both groups, and levels of sTREM-1 were low (<0.2 ng/ml) in both CF patients and healthy volunteers (Fig. 4C). These ELISA data were further confirmed via Western blot analysis (Fig. 4D).
###end p 61
###begin title 62
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Circulating monocytes from CF but not COPD patients fail to overexpress TREM-1 at the cell surface upon LPS stimulation
###end title 62
###begin p 63
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-KlesneyTait1">[7]</xref>
###xml 120 123 120 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Knapp1">[8]</xref>
###xml 255 258 255 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-GomezPina1">[9]</xref>
###xml 519 543 519 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g005">Fig. 5A and B, gray bars</xref>
###xml 700 727 700 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g005">Fig. 5A and B, hatched bars</xref>
###xml 814 821 814 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 845 870 845 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g005">Fig. 5A and B, solid bars</xref>
###xml 1330 1339 1330 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g005">figure 5C</xref>
Previous studies have demonstrated a fast up-regulation of membrane-anchored TREM-1 expression after LPS challenge [7], [8]. Considering our previous findings, we next analyzed levels of TREM-1 in CF monocytes stimulated with LPS. As we have shown before [9], a time course analysis of TREM-1 expression revealed that levels of this receptor increase in a time-dependent manner in monocytes isolated from healthy controls, reaching a maximum (three-fold increase over basal levels) about six hours after LPS challenge (Fig. 5A and B, gray bars). TREM-1 expression increased to similar levels in COPD monocytes 1 h after stimulation, but appeared to reach a maximum earlier than in control monocytes (Fig. 5A and B, hatched bars). In striking contrast, receptor expression was not up-regulated in CF monocytes upon ex vivo endotoxin stimulation (Fig. 5A and B, solid bars). In addition, and to exclude that the observed effect might be due to a reduction in the number of TREM-1 positive cells, we performed another experiment with monocytes isolated from five of each of the three groups studied (randomly selected from the previously discussed sets). Cultures of circulating monocytes were stimulated, or not, with LPS for 1 hour. Next, cells were double-stained with TREM-1-FITC and CD14-APC, and analyzed by flow cytometry. As figure 5C shows, about 90% of cells were CD14+ in all conditions analyzed. Control cells stimulated with LPS exhibit an average of 40% CD14+/TREM-1 positive cells, and a similar result was obtained for COPD monocytes. In contrast, CF cells exhibit low levels of CD14+/TREM-1+ cells (less than 5%), and they did not increase significantly their basal levels of TREM-1 after LPS stimulation. No significant cell viability changes were detected in both CF and COPD monocytes (data not shown).
###end p 63
###begin title 64
CF but not COPD monocytes fail to induce TREM-1 expression after LPS stimulation.
###end title 64
###begin p 65
###xml 618 625 618 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 517 525 <span type="species:ncbi:9606">patients</span>
###xml 532 540 <span type="species:ncbi:9606">patients</span>
(A) Cultures of human monocytes from healthy volunteers (control, gray bars, n = 10) CF patients (CF, solid bars, n = 20) and COPD patients (COPD, hatched bars, n = 10) were treated with 10 ng/ml LPS for indicated times. Next, cells were harvested and stained with anti-TREM-1-FITC and analyzed by flow cytometry. The fraction of positive cells is given as % of total cells (A) and MFIs (B). The percentage of CD14 and TREM-1 positive cells was analyzed in monocytes from five of each of the studied groups (i.e., CF patients, COPD patients and healthy individuals; all samples were randomly selected), treated or not ex vivo with LPS for 1 hour. The flow cytometry analysis of these cells simultaneously stained with CD14-APC and TREM-1-FITC is shown (C). Supernatants from the same experiment (shown in panels A and B) were centrifuged at 400xg to remove detached cells and possible cellular debris. The concentration of sTREM-1 in the supernatants was analyzed with a commercial ELISA. The mean concentration of sTREM-1 in ng/ml is given (D). *, p<0.05 and **, p<0.01 with respect to similarly treated monocytes from healthy individuals.
###end p 65
###begin p 66
###xml 328 335 328 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g005">Fig. 5D</xref>
###xml 592 611 592 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g005">Fig. 5D, solid bars</xref>
###xml 87 92 <span type="species:ncbi:9606">human</span>
We also verified that sTREM-1 is not detected in supernatants of untreated cultures of human monocytes isolated from healthy volunteers, which implies levels below 15 pg/ml. However, concentration of this soluble form was notably enhanced in the supernatants of both control and COPD cultures after 16 hours of LPS stimulation (Fig. 5D). In our model, reduced cell surface expression of TREM-1 was always accompanied by a concomitant increase in sTREM-1 levels in culture supernatants. By contrast, cultures of CF monocytes did not contain detectable levels of sTREM-1 after LPS stimulation (Fig. 5D, solid bars).
###end p 66
###begin p 67
###xml 96 105 96 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g006">Figure 6A</xref>
###xml 457 464 457 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g006">Fig. 6B</xref>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 245 253 <span type="species:ncbi:9606">patients</span>
We further confirmed these results by immunofluorescence and Western blot analysis. As shown in Figure 6A, significant TREM-1 expression is observed in cultures of human monocytes treated with LPS for 6 h but not in those cells isolated from CF patients. In addition, these experiments clearly demonstrate membrane localization of mature TREM-1. On the other hand, the absence of sTREM-1 in the supernatant of CF cultures was confirmed by Western blotting (Fig. 6B).
###end p 67
###begin title 68
TREM-1 is not induced in CF monocytes upon LPS challenge.
###end title 68
###begin p 69
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 475 483 <span type="species:ncbi:9606">patients</span>
(A) Cultures of human monocytes from healthy volunteers and CF patients were treated with 10 ng/ml LPS for 6 hours, stained with an anti-TREM-1 antibody (green), and nuclei were localized via standard staining with Hoechst 33342 (blue). A typical result of three independent experiments is shown (I, anti-TREM-1; II, merged anti-TREM-1 and Hoechst 33342). (B) Cell supernatants from monocyte cultures (one from a healthy volunteer (control) and two from randomly selected CF patients) were stimulated with LPS or not (0) for 6 and 18 h, and then centrifuged at 400xg to remove detached cells and possible cellular debris. A Western blot analysis of these supernatants was performed using an anti-TREM-1 commercial antibody that recognizes the extracellular domain of the receptor. Notice detection of a band of approximately 27 kDa in this condition (arrow). Loading controls are also shown (membrane stained with Ponceau red, lower panel). The results of a typical experiment from three experiments performed are shown.
###end p 69
###begin title 70
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Levels of PGE2 do not account for TREM-1 down-regulation in CF monocytes
###end title 70
###begin p 71
###xml 60 61 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Murakami1">[13]</xref>
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 365 366 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 495 496 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 546 552 546 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g007">Fig. 7</xref>
###xml 615 616 615 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
###xml 647 652 <span type="species:ncbi:9606">human</span>
It has been recently demonstrated that prostaglandin E2 (PGE2) plays an important role in the control of TREM-1 expression [13]. In particular, Murakami and coworkers suggest that LPS-induced TREM-1 expression on macrophages is mediated by endogenous PGE2. To examine possible mechanisms underlying TREM-1 down-regulation in CF patients, we determined levels of PEG2 in monocytes from CF and healthy volunteers. However, and contrary to expectations, there were no significant differences in PGE2 concentrations between CF and control monocytes (Fig. 7). This finding indicates that other factors in addition to PEG2 modulate TREM-1 expression in human monocytes.
###end p 71
###begin title 72
###xml 13 14 13 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Levels of PGE2 are similar in CF monocytes and controls.
###end title 72
###begin p 73
###xml 193 194 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 220 221 220 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Cultures of human monocytes from healthy volunteers (control, gray bars, n = 10) and CF patients (CF, solid bars, n = 20) were treated with 10 ng/ml LPS for indicated hours. Next, levels of PGE2 were analyzed using a PGE2 EIA kit.
###end p 73
###begin title 74
###xml 74 82 <span type="species:ncbi:9606">patients</span>
High levels of nuclear PU.1 in circulating monocytes from cystic fibrosis patients
###end title 74
###begin p 75
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Zeng1">[40]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-DeKoter1">[41]</xref>
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TREM-1</italic>
###xml 600 608 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g008">Figure 8</xref>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
###xml 692 700 <span type="species:ncbi:9606">patients</span>
###xml 856 864 <span type="species:ncbi:9606">patients</span>
It has been recently reported that activation of the transcription factor p65 is necessary for expression of TREM-1, whereas another transcription factor, PU.1, inhibits TREM-1 up-regulation [40]. PU.1 is highly expressed in cells of the immune system and regulates several genes in, e.g., macrophages and B cells [41]. Apparently, in response to LPS challenge both factors bind to the TREM-1 promoter in macrophages. To analyze possible mechanisms underlying TREM-1 down-regulation in CF patients, we determined levels of p65 and PU.1 in nuclei isolated from CF monocytes and healthy volunteers. As Figure 8 shows, PU.1 but not p65 is differentially activated in untreated monocytes from CF patients versus controls. These findings suggest that PU.1 activation plays an important role in the mechanism leading to TREM-1 down-regulation in cystic fibrosis patients.
###end p 75
###begin title 76
Levels of PU.1 but not of p65 are up-regulated in CF monocytes.
###end title 76
###begin p 77
###xml 135 143 <span type="species:ncbi:9606">patients</span>
Nuclear protein fractions were isolated from circulating monocytes obtained from healthy volunteers (control, gray bars, n = 5) and CF patients (CF, solid bars, n = 10). Western blot analysis was performed using anti-p65 and anti-PU.1 antibodies. Normalization was carried out with an anti-alpha-actin antibody. The average of densitometer analysis of each Western blot is shown (n = 5). *, p<0.05 with respect to healthy controls.
###end p 77
###begin title 78
Discussion
###end title 78
###begin p 79
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Norman1">[42]</xref>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Elborn1">[43]</xref>
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Jaresova1">[44]</xref>
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Massengale1">[45]</xref>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Hartl1">[46]</xref>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
###xml 462 470 <span type="species:ncbi:9606">patients</span>
###xml 607 615 <span type="species:ncbi:9606">patients</span>
Although previous investigations have revealed a hyperinflammatory state in CF patients [42], [43], [44], the observed high frequency of pathogen colonization in these patients points to a significant deficiency of their innate immune systems. Several studies conducted so far have focused on local and resident cells (e.g., lung epithelial cells or recruited neutrophils), and have demonstrated a defective IL-8 secretion by CF-airway epithelial cells in these patients [45]. On the other hand, a recently published article presents an interesting mechanism by which neutrophils fail to be activated in CF patients' lungs [46]. The unopposed elastolytic activity in the airways of individuals with CF leads to CXCR1 cleavage on neutrophils, thus disabling their bacterial-killing capacity.
###end p 79
###begin p 80
###xml 203 207 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Norman1">[42]</xref>
###xml 244 248 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Elborn1">[43]</xref>
###xml 304 317 300 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 581 594 577 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 600 607 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002667-t003">Table 3</xref>
###xml 686 693 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 831 844 827 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1028 1036 1020 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002667-g001">Figure 1</xref>
###xml 1205 1209 1193 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Muir1">[47]</xref>
###xml 1337 1341 1321 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Jaresova1">[44]</xref>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
###xml 304 317 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 390 398 <span type="species:ncbi:9606">patients</span>
###xml 535 543 <span type="species:ncbi:9606">patients</span>
###xml 581 594 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 831 844 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1471 1479 <span type="species:ncbi:9606">patients</span>
###xml 1599 1607 <span type="species:ncbi:9606">patients</span>
###xml 1728 1736 <span type="species:ncbi:9606">patients</span>
In contrast, the inflammatory responses of circulating cells in CF patients have not been properly described so far. Previous works indicate that levels of TNFalpha in CF patients could be either higher [42] or lower than in healthy volunteers [43]. These differences appear to be due to the presence of P. aeruginosa infection and/or antibiotic treatment, but the small number of enrolled patients (14 and 10, respectively) does not allow for a statistically meaningful comparison. Here we show that monocytes isolated from twenty CF patients, fourteen of which were colonized by P. aeruginosa (see Table 3), are unable to mount a proper inflammatory response when they are challenged ex vivo with the major immunogenic component of Gram-negative bacteria, LPS. Besides, this feature is irrespective of the presence or absence of P. aeruginosa infection. The low levels of two critical pro-inflammatory cytokines, TNF-alpha and IL-6, produced by these cells indicate that they could not properly respond to a bacterial insult (Figure 1). Our findings are in agreement with the significantly lower IL-8 production in DeltaF508 CF cell line compared to a normal airway epithelial cells after LPS challenge [47], but are at odds with the higher levels of TNFalpha expression in CF monocytes stimulated with LPS recently reported by others [44]. This discrepancy might result from the use of a 10-fold higher LPS concentration by Jaresova and co-workers. Besides, only nine patients were included in the latter study. Additional studies of immune responses by CF monocytes enrolling a larger number of patients will be needed to gain further insight into the mechanisms that ultimately result in chronic lung colonization in these patients.
###end p 80
###begin p 81
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Muir1">[47]</xref>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
Our current results suggest that the observed refractory state in CF patients was not secondary to impaired LPS recognition by circulating CF monocytes. Indeed, we observed normal levels of TLR4, MD2 and CD14 in cells from CF patients and healthy individuals; similar observations were made for other elements of the intracellular TLR signaling pathway. These data are in line with those reported by Muir and coworkers, who showed that the expression of TLRs is not directly affected by CFTR dysfunction in different types of airway epithelial cells [47].
###end p 81
###begin p 82
###xml 77 95 77 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella abortus</italic>
###xml 269 279 269 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. abortus</italic>
###xml 370 383 370 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Dehus1">[48]</xref>
###xml 403 410 403 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 444 454 444 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. abortus</italic>
###xml 616 626 616 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">aeruginosa</italic>
###xml 360 368 <span type="species:ncbi:9606">patients</span>
###xml 370 383 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 613 626 <span type="species:ncbi:287">P. aeruginosa</span>
Note that in our experiments we have used a purified lipopolysaccharide from Salmonella abortus generously provided by Dr. Chris Galanos (Max Planck, Freiburg, Germany). Recently, a thorough study that compared endotoxins from different sources indicated that LPS from S. abortus is more potent than the one generated by the bacteria most commonly found in CF patients, P. aeruginosa[48]. Despite this, ex vivo stimulation of CF monocytes with S. abortus LPS did not generate the pro-inflammatory response observed in cells from healthy controls. It is therefore safe to assume that challenging CF monocytes with P. aeruginosa LPS would lead to similar or even less pronounced responses.
###end p 82
###begin p 83
###xml 206 209 206 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Bouchon1">[6]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Haselmayer1">[11]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Mohamadzadeh1">[12]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Determann1">[17]</xref>
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Gibot8">[39]</xref>
###xml 459 466 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
###xml 608 616 <span type="species:ncbi:9606">patients</span>
Several recent reports demonstrate an important role for TREM-1 in inflammation during an infectious disease; the receptor appears to act as an amplifier of the immune response in the presence of pathogens [6], [11], [12], [17], [39]. In line with these findings, we observed that circulating monocytes from patients who suffer from CF showed significantly decreased basal levels of TREM-1. In addition, the receptor was not up-regulated upon LPS stimulation ex vivo. These observations suggest that down-regulation of surface exposed TREM-1 might at least partly underlie the non-responsiveness state in CF patients.
###end p 83
###begin p 84
###xml 216 219 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-GomezPina1">[9]</xref>
###xml 899 906 899 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002667-t004">Table 4</xref>
###xml 978 982 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Radsak1">[49]</xref>
###xml 455 463 <span type="species:ncbi:9606">patients</span>
###xml 674 682 <span type="species:ncbi:9606">patients</span>
###xml 863 871 <span type="species:ncbi:9606">patients</span>
Previous work from our laboratory indicated that soluble TREM-1 is generated after LPS challenge or pathogen infection via limited proteolysis of membrane-anchored receptor by LPS-activated matrix metalloproteinases [9]. However, the low levels of TREM-1 expression on the cell surface of CF monocytes do not seem to be explained by proteolytic processing of the full-length receptor, as there are no significant differences in sTREM-1 levels found in CF patients and healthy volunteers. Thus, the clear disparity in TREM-1 levels on the monocyte surface between CF and controls cannot be explained by an exacerbated proteolytic attack secondary to pathogen infection in CF patients. In this regard, we notice that the kinetics of TREM-1 expression upon LPS stimulation was not significantly different in healthy volunteers and in the extra control group of COPD patients included in our study (see Table 4). Similar results have been recently reported by Radsak and co-workers [49]. Further, analysis of proinflammatory cytokines revealed that COPD monocytes are not locked in an endotoxin tolerance state (data not shown).
###end p 84
###begin p 85
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Murakami1">[13]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Zeng1">[40]</xref>
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Zeng1">[40]</xref>
###xml 362 368 <span type="species:ncbi:10090">murine</span>
Both PGE2 and p65 have been described as positive regulators of TREM-1 expression [13], [40]. However, our results also seem to exclude a reduction in PGE2 levels and deficient activation of p65 as part of the molecular mechanism that leads to the observed tolerance state. On the other hand, the transcription factor PU.1 is known to block TREM-1 expression in murine macrophages [40]. In line with this finding, we have detected high levels of PU.1 in nuclei isolated from CF monocytes.
###end p 85
###begin p 86
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Zeng1">[40]</xref>
###xml 491 495 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Xu1">[50]</xref>
###xml 655 659 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Dorin1">[51]</xref>
###xml 661 665 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Wilkinson1">[52]</xref>
###xml 737 741 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Yang1">[53]</xref>
###xml 743 747 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Mouri1">[54]</xref>
###xml 797 801 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Lichanska1">[55]</xref>
###xml 803 807 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Henkel1">[56]</xref>
###xml 925 937 919 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cftr&#916;508</italic>
###xml 943 947 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Xu2">[57]</xref>
###xml 1042 1046 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Hoefnagel1">[58]</xref>
###xml 1299 1303 1289 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002667-Schoni1">[59]</xref>
###xml 1419 1425 1409 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TREM-1</italic>
###xml 191 199 <span type="species:ncbi:9606">patients</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 646 654 <span type="species:ncbi:9606">patients</span>
###xml 938 942 <span type="species:ncbi:10090">mice</span>
###xml 1108 1116 <span type="species:ncbi:9606">patients</span>
###xml 1375 1380 <span type="species:ncbi:9606">human</span>
Currently, we can only speculate about the mechanisms that link defective CFTR functioning to TREM-1 down-regulation. One appealing hypothesis is that changes in the ion concentrations in CF patients induce PU.1 activation and subsequent TREM-1 down-regulation in their monocytes [40]. Interestingly, Xu and co-workers have reported that IL-1beta and the related S100 calcium-binding proteins, calgranulin A and B (S100A8 and A9, respectively), are up-regulated in mice with CFTR deficiency [50]. In fact, elevated concentrations of these proteins, which have been alternatively termed CF antigen (CFAg), have long been detected in serum from CF patients [51], [52]. On the other hand, other authors have demonstrated that both IL-1beta [53], [54] and S100A8 / A9 are induced upon PU.1 activation [55], [56]. Also along these lines, a recent study suggests a clear down-regulation of the transcriptional repressor, Foxp1, in cftrDelta508 mice [57]; independent studies have established that this occurs in the presence of high levels of PU.1 [58]. Altogether, a likely pathway of monocyte inactivation in CF patients begins to emerge. Several lines of evidence indicate that transcription factor PU.1 is activated in CF models, perhaps in response to an elevated intracellular calcium concentration [59]. The transcription factor then accumulates at high levels in nuclei of human CF monocytes, ultimately resulting in TREM-1 repression. The final result is a diminished expression of membrane-anchored TREM-1, which aborts the positive feed-back loop needed for mounting a strong response against invading pathogens.
###end p 86
###begin p 87
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 309 317 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
###xml 594 602 <span type="species:ncbi:9606">patients</span>
In conclusion, our data suggest that circulating monocytes from CF patients are "locked" in an endotoxin tolerance state, which results at least in part from a notable down-regulation of TREM-1 expression. These findings open new avenues for the characterization and treatment of inflammatory responses in CF patients. Our results suggest that not only resident immune cells but also circulating monocytes are affected in CF patients, and are unable to respond properly to LPS challenge. We suggest that this information should be considered while developing new anti-infection therapies in CF patients.
###end p 87
###begin title 88
References
###end title 88
###begin article-title 89
Cystic fibrosis.
###end article-title 89
###begin article-title 90
The ABC protein turned chloride channel whose failure causes cystic fibrosis.
###end article-title 90
###begin article-title 91
Cystic fibrosis.
###end article-title 91
###begin article-title 92
Cystic fibrosis: a polymicrobial infectious disease.
###end article-title 92
###begin article-title 93
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Management of pulmonary disease in patients with cystic fibrosis.
###end article-title 93
###begin article-title 94
Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.
###end article-title 94
###begin article-title 95
The TREM receptor family and signal integration.
###end article-title 95
###begin article-title 96
###xml 109 114 <span type="species:ncbi:9606">human</span>
Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia.
###end article-title 96
###begin article-title 97
###xml 77 82 <span type="species:ncbi:9606">human</span>
Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes.
###end article-title 97
###begin article-title 98
###xml 48 52 <span type="species:ncbi:10090">mice</span>
TREM-1 promotes survival during septic shock in mice.
###end article-title 98
###begin article-title 99
TREM-1 ligand expression on platelets enhances neutrophil activation.
###end article-title 99
###begin article-title 100
###xml 66 71 <span type="species:ncbi:9606">human</span>
Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses.
###end article-title 100
###begin article-title 101
Lipopolysaccharide-induced up-regulation of triggering receptor expressed on myeloid cells-1 expression on macrophages is regulated by endogenous prostaglandin E2.
###end article-title 101
###begin article-title 102
Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
###end article-title 102
###begin article-title 103
Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.
###end article-title 103
###begin article-title 104
###xml 110 116 <span type="species:ncbi:10090">murine</span>
A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis.
###end article-title 104
###begin article-title 105
Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia.
###end article-title 105
###begin article-title 106
Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis.
###end article-title 106
###begin article-title 107
Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection.
###end article-title 107
###begin article-title 108
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report.
###end article-title 108
###begin article-title 109
Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
###end article-title 109
###begin article-title 110
Expression of the triggering receptor expressed on myeloid cells-1 mRNA in a heterogeneous infected population.
###end article-title 110
###begin article-title 111
The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.
###end article-title 111
###begin article-title 112
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
###end article-title 112
###begin article-title 113
Evaluation of clinical methods for rating dyspnea.
###end article-title 113
###begin article-title 114
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.
###end article-title 114
###begin article-title 115
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients.
###end article-title 115
###begin article-title 116
###xml 23 28 <span type="species:ncbi:9606">human</span>
Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4.
###end article-title 116
###begin article-title 117
Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation.
###end article-title 117
###begin article-title 118
###xml 25 47 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 56 84 <span type="species:ncbi:87882">Burkholderia cepacia complex</span>
Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
###end article-title 118
###begin article-title 119
Infection control in cystic fibrosis.
###end article-title 119
###begin article-title 120
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
###end article-title 120
###begin article-title 121
Inflammatory responses associated with acute coronary syndrome up-regulate IRAK-M and induce endotoxin tolerance in circulating monocytes.
###end article-title 121
###begin article-title 122
IRAK-M is a negative regulator of Toll-like receptor signaling.
###end article-title 122
###begin article-title 123
Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state.
###end article-title 123
###begin article-title 124
Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia.
###end article-title 124
###begin article-title 125
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections.
###end article-title 125
###begin article-title 126
###xml 95 99 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats.
###end article-title 126
###begin article-title 127
The therapeutic potential of TREM-1 modulation in the treatment of sepsis and beyond.
###end article-title 127
###begin article-title 128
TREM-1 expression in macrophages is regulated at transcriptional level by NF-kappaB and PU.1.
###end article-title 128
###begin article-title 129
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.
###end article-title 129
###begin article-title 130
Plasma tumour necrosis factor alpha in cystic fibrosis.
###end article-title 130
###begin article-title 131
###xml 65 73 <span type="species:ncbi:9606">patients</span>
In vitro tumor necrosis factor-alpha secretion by monocytes from patients with cystic fibrosis.
###end article-title 131
###begin article-title 132
###xml 140 148 <span type="species:ncbi:9606">patients</span>
Kinetics of Toll-like receptor-4 splice variants expression in lipopolysaccharide-stimulated antigen presenting cells of healthy donors and patients with cystic fibrosis.
###end article-title 132
###begin article-title 133
Reduced interleukin-8 production by cystic fibrosis airway epithelial cells.
###end article-title 133
###begin article-title 134
Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease.
###end article-title 134
###begin article-title 135
Toll-like receptors in normal and cystic fibrosis airway epithelial cells.
###end article-title 135
###begin article-title 136
Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay.
###end article-title 136
###begin article-title 137
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease.
###end article-title 137
###begin article-title 138
Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency.
###end article-title 138
###begin article-title 139
A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene.
###end article-title 139
###begin article-title 140
Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues.
###end article-title 140
###begin article-title 141
NF-IL6 (C/EBPbeta ) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether.
###end article-title 141
###begin article-title 142
###xml 39 44 <span type="species:ncbi:9606">human</span>
Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1.
###end article-title 142
###begin article-title 143
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU.1.
###end article-title 143
###begin article-title 144
Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells.
###end article-title 144
###begin article-title 145
Functional genomic responses to cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR(delta508) in the lung.
###end article-title 145
###begin article-title 146
Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma.
###end article-title 146
###begin article-title 147
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Intracellular free calcium levels in mononuclear cells of patients with cystic fibrosis and normal controls.
###end article-title 147
###begin p 148
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 148
###begin p 149
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: MEC and FMMA
###end p 149

